Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia

Haematologica

Volumn 98, Issue 5, 2013, Pages

  Beekman, Renée ^a   Valkhof, Marijke ^a   van Strien, Paulette ^a   Valk, Peter J M ^a   Touw, Ivo P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute myeloid leukemia; Colony stimulating factor 3 receptor mutation; Severe congenital neutropenia

Indexed keywords

ASPARAGINE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; ISOLEUCINE; REACTIVE OXYGEN METABOLITE; THREONINE; COLONY STIMULATING FACTOR RECEPTOR; CSF3R PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; CELL PROLIFERATION; COLONY STIMULATING FACTOR 3 RECEPTOR GENE; CYTOGENETICS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DISEASE COURSE; GENE; GENE MUTATION; HUMAN; HYDROPHOBICITY; LETTER; MYELOID PROGENITOR CELL; NONHUMAN; NONSENSE MUTATION; PREVALENCE; SEVERE CONGENITAL NEUTROPENIA; ANIMAL; GENETICS; MOUSE; MUTATION; MUTATION RATE; NEUTROPENIA;

ANIMALS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MUTATION; MUTATION RATE; NEUTROPENIA; RECEPTORS, COLONY-STIMULATING FACTOR;

EID: 84877018599     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.085050     Document Type: Letter

References (15)

1. Irandoust MI, Aarts LH, Roovers O, Gits J, Erkeland SJ, Touw IP. Suppressor of cytokine signaling 3 controls lysosomal routing of GCSF receptor. Embo J. 2007;26(7):1782-93.
2. Wolfler A, Irandoust M, Meenhuis A, Gits J, Roovers O, Touw IP. Site-specific ubiquitination determines lysosomal sorting and signal attenuation of the granulocyte colony-stimulating factor receptor. Traffic. 2009;10(8):1168-79.
3. Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993;81(10):2496-502.
4. Dale DC, Link DC. The many causes of severe congenital neutropenia. N Engl J Med. 2009;360(1):3-5.
5. Touw IP, van de Geijn GJ. Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and elated blood cell disorders. Front Biosci. 2007;12:800-15.
6. Germeshausen M, Skokowa J, Ballmaier M, Zeidler C, Welte K. GCSF receptor mutations in patients with congenital neutropenia. Curr Opin Hematol. 2008;15(4):332-7.
7. Dong F, Dale DC, Bonilla MA, Freedman M, Fasth A, Neijens HJ, et al. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia. 1997;11(1):120-5.
8. Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood. 2007;109(1):93-9.
9. Link DC, Kunter G, Kasai Y, Zhao Y, Miner T, McLellan MD, et al. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood. 2007;110(5):1648-55.
10. Forbes LV, Gale RE, Pizzey A, Pouwels K, Nathwani A, Linch DC. An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. Oncogene. 2002;21(39):5981-9.
11. Dong F, van Paassen M, van Buitenen C, Hoefsloot LH, Lowenberg B, Touw IP. A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G-CSF-R isoform. Blood. 1995;85(4):902-11.
12. Beekman R, Valkhof MG, Sanders MA, van Strien PM, Haanstra JR, Broeders L, et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood. 2012;119(22):5071-7.
13. Plo I, Zhang Y, Le Couedic JP, Nakatake M, Boulet JM, Itaya M, et al. An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia. J Exp Med. 2009;206(8):1701-7.
14. Lowenberg B, van Putten WL, Touw IP, Delwel R, Santini V. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. N Engl J Med. 1993;328(9):614-9.
15. Zhu QS, Xia L, Mills GB, Lowell CA, Touw IP, Corey SJ. G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth. Blood. 2006;107(5):1847-56.